Cargando…
Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745633/ https://www.ncbi.nlm.nih.gov/pubmed/36523943 http://dx.doi.org/10.21037/hbsn-22-459 |
| _version_ | 1784849191572340736 |
|---|---|
| author | Lonardo, Amedeo |
| author_facet | Lonardo, Amedeo |
| author_sort | Lonardo, Amedeo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9745633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97456332022-12-14 Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? Lonardo, Amedeo Hepatobiliary Surg Nutr Editorial AME Publishing Company 2022-12 /pmc/articles/PMC9745633/ /pubmed/36523943 http://dx.doi.org/10.21037/hbsn-22-459 Text en 2022 Hepatobiliary Surgery and Nutrition. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Lonardo, Amedeo Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title | Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title_full | Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title_fullStr | Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title_full_unstemmed | Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title_short | Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| title_sort | can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745633/ https://www.ncbi.nlm.nih.gov/pubmed/36523943 http://dx.doi.org/10.21037/hbsn-22-459 |
| work_keys_str_mv | AT lonardoamedeo canmetabolomicsignaturefosterprecisionmedicineapproachesinnonalcoholicfattyliverdiseasearena |